-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Short Interest in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXW) Declines By 52.6%
Short Interest in Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXW) Declines By 52.6%
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXW – Get Rating) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 900 shares, a drop of 52.6% from the September 30th total of 1,900 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 0.1 days.
Hedge Funds Weigh In On Phoenix Biotech Acquisition
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Context Capital Management LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the first quarter worth about $44,000. Clear Street LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the second quarter worth about $33,000. Finally, MMCAP International Inc. SPC grew its stake in shares of Phoenix Biotech Acquisition by 200.0% during the first quarter. MMCAP International Inc. SPC now owns 375,000 shares of the company's stock worth $82,000 after acquiring an additional 250,000 shares during the last quarter.
Get Phoenix Biotech Acquisition alerts:Phoenix Biotech Acquisition Stock Performance
Shares of Phoenix Biotech Acquisition stock remained flat at $0.03 during trading on Thursday. The stock had a trading volume of 151,305 shares, compared to its average volume of 23,308. Phoenix Biotech Acquisition has a 1 year low of $0.02 and a 1 year high of $0.58. The firm's 50-day moving average is $0.07 and its two-hundred day moving average is $0.10.
About Phoenix Biotech Acquisition
(Get Rating)Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
Recommended Stories
- Get a free copy of the StockNews.com research report on Phoenix Biotech Acquisition (PBAXW)
- The Institutions Box Up Dividend Growth with These Cheap Stocks
- Be Sure You Own United Parcel Service for the Right Reasons
- Strong Fundamentals Make Bristol Myers Squibb Stock a Real Value
- Sell-Siders See Value in Highly Valued Chipotle Stock
- 3 Roughed-Up Dividend Aristocrats with Good Long-Term Prospects
Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Phoenix Biotech Acquisition Corp. (NASDAQ:PBAXW – Get Rating) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 900 shares, a drop of 52.6% from the September 30th total of 1,900 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 0.1 days.
凤凰生物科技收购公司(纳斯达克:PBAXW-GET评级)是空头股数10月份大幅下跌的目标。截至10月15日,空头股数共有900股,比9月30日的1900股减少了52.6%。以日均成交量12,800股计算,目前天数与回补比率为0.1天。
Hedge Funds Weigh In On Phoenix Biotech Acquisition
对冲基金参与凤凰生物科技的收购
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Context Capital Management LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the first quarter worth about $44,000. Clear Street LLC purchased a new stake in shares of Phoenix Biotech Acquisition during the second quarter worth about $33,000. Finally, MMCAP International Inc. SPC grew its stake in shares of Phoenix Biotech Acquisition by 200.0% during the first quarter. MMCAP International Inc. SPC now owns 375,000 shares of the company's stock worth $82,000 after acquiring an additional 250,000 shares during the last quarter.
几家机构投资者和对冲基金最近增持或减持了该股。Context Capital Management LLC在第一季度购买了凤凰生物科技收购的新股份,价值约44,000美元。Clear Street LLC在第二季度购买了凤凰生物科技收购的新股份,价值约3.3万美元。最后,MMCAP国际公司在第一季度收购的菲尼克斯生物科技公司的股份增加了200.0%。MmCap International Inc.SPC现在持有375,000股该公司股票,价值82,000美元,此前该公司在上个季度增持了250,000股。
Phoenix Biotech Acquisition Stock Performance
凤凰生物科技收购股票表现
Shares of Phoenix Biotech Acquisition stock remained flat at $0.03 during trading on Thursday. The stock had a trading volume of 151,305 shares, compared to its average volume of 23,308. Phoenix Biotech Acquisition has a 1 year low of $0.02 and a 1 year high of $0.58. The firm's 50-day moving average is $0.07 and its two-hundred day moving average is $0.10.
在周四的交易中,凤凰生物科技收购股票的股价持平于0.03美元。该股成交量为151,305股,而其平均成交量为23,308股。凤凰生物科技收购的一年低点为0.02美元,一年高位为0.58美元。该公司的50日移动均线切入位在0.07美元,200日移动均线切入位在0.10美元。
About Phoenix Biotech Acquisition
关于收购菲尼克斯生物科技公司
Phoenix Biotech Acquisition Corp. intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the life sciences sector. The company was incorporated in 2021 and is based in Oakland, California.
菲尼克斯生物技术收购公司打算通过合并、股份交换、股份购买、重组或类似的业务合并来收购资产和业务。它专注于在生命科学领域寻找机会。该公司成立于2021年,总部设在加利福尼亚州奥克兰。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Phoenix Biotech Acquisition (PBAXW)
- The Institutions Box Up Dividend Growth with These Cheap Stocks
- Be Sure You Own United Parcel Service for the Right Reasons
- Strong Fundamentals Make Bristol Myers Squibb Stock a Real Value
- Sell-Siders See Value in Highly Valued Chipotle Stock
- 3 Roughed-Up Dividend Aristocrats with Good Long-Term Prospects
- 免费获取StockNews.com关于凤凰生物科技收购的研究报告(PBAXW)
- 这些机构用这些廉价股票限制股息增长
- 确保您拥有联合包裹服务公司的理由是正确的
- 强劲的基本面使百时美施贵宝股票成为真正的价值
- 卖方-旁观者看到高估值Chipotle股票的价值
- 3位长期前景良好的粗制滥造股息贵族
Receive News & Ratings for Phoenix Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phoenix Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
获得《凤凰生物科技收购日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对菲尼克斯生物技术收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧